Dss's impact biomedical receives us patent for its functional fragrance formulation mosquito repellant booster

Rochester, n.y., june 16, 2021 (globe newswire) -- document security systems, inc. (“dss” or the “company”) (nyse american: dss), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced its wholly owned subsidiary impact biomedical, inc. (“impact biomedical”) received notice of issuance (us 10,966,424) from the u.s. patent and trademark office (“uspto”) for 3fdb, a functional fragrance formulation (3f) technology that increases the effectiveness of current mosquito repellants through a delightfully fragrant compound derived from botanical oils.
DSS Ratings Summary
DSS Quant Ranking